<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="368853">
  <stage>Registered</stage>
  <submitdate>29/06/2015</submitdate>
  <approvaldate>27/07/2015</approvaldate>
  <actrnumber>ACTRN12615000779572</actrnumber>
  <trial_identification>
    <studytitle>Study on survival from prolonged cardiac arrest  treated with an artificial blood pump (ECMO) </studytitle>
    <scientifictitle>Survival outcomes in patients who have had prolonged cardiac arrest treated with artificial blood pump suppor</scientifictitle>
    <utrn>U1111-1171-6852</utrn>
    <trialacronym>2CHEER</trialacronym>
    <secondaryid>none</secondaryid>
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>refractory cardiac arrest</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Mechanical chest compressions with a Lucas Device, commenced either in-hospital (cardiac arrest team) or out-of-hospital (by paramedics)
Induced hypothermia with 2L of intravenouse ice-cold saline, commenced by paramedics, Emergency Department or ICU staff.
Peripheral veno-arterial ECMO support (by anaesthetists and surgeons) to facilitate early revascularisation (if indicated) by cardiologists.

Neurological prognostication will be performed at 96 hours to determine limits of therapy. 

The overall duration of ECMO support is anticipated to be approximately 2-5 days</interventions>
    <comparator>no controll group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Survival  </outcome>
      <timepoint>90 days following cardiac arrest</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Level of neurological function as assessed by Cerebral Performance Category and modified Rankin Scale</outcome>
      <timepoint>90 days following cardiac arrest</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Return of spontaneous circulation as assessed by investigators
</outcome>
      <timepoint>Time following cardiac arrest (hours)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Successful weaning from ECMO support as assessed by investigators</outcome>
      <timepoint>Time following cardiac arrest (hours)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>In-and out-of-hospital cardiac arrest, refractory to conventional ACLS
Witnessed cardiac arrest
Potentially reversible aetiology
No major known co-morbidities</inclusivecriteria>
    <inclusiveminage>12</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Known major co-morbidities</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>In- and out-of-hospital patients who meet study inclusion criteria and who do not have exclusion criteria will be enrolled</concealment>
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>3/08/2015</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate>1/06/2018</anticipatedenddate>
    <actualenddate />
    <samplesize>25</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Royal Prince Alfred Hospital - Camperdown</hospital>
    <hospital>St Vincent's Hospital (Darlinghurst) - Darlinghurst</hospital>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>A/Prof Paul Forrest</primarysponsorname>
    <primarysponsoraddress>Department of Anaesthetics
Royal Prince Alfred Hospital
Missenden Road
Camperdown
NSW 2050</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Maquet Getinge Group</fundingname>
      <fundingaddress>MAQUET CARDIOPULMONARY AG 
Kehler Strasse 31
76437 Rastatt
Germany

</fundingaddress>
      <fundingcountry>Germany</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>PhysioControl</fundingname>
      <fundingaddress>Physio-Control Australia Pty Ltd
Suite 4.01, 15 Orion Road Lane Cove, NSW 2066</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr. David Lowe</sponsorname>
      <sponsoraddress>Department of Intensive Care
St. Vincent's Hospital
Victoria St
Darlinghurst
NSW 2011</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Other Collaborative groups</othercollaboratortype>
      <othercollaboratorname>NSW Ambulance Service</othercollaboratorname>
      <othercollaboratoraddress>NSW Ambulance State Headquarters
Balmain Road
Rozelle
NSW 2040</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Only a few patients (less than 10%) survive cardiac arrest that lasts for more than 30 minutes, even if the cause is potentially reversible.
ECMO is a blood pump that can be placed in large blood vessels in the groin and takes over the functions of the heart and lungs.
This study will look at how many people survive persisting cardiac arrest when ECMO is used to support the heart until the cause of the cardiac arrest has been treated and the heart has had time to recover.
</summary>
    <trialwebsite>none</trialwebsite>
    <publication>none</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney Local Health District Ethics Review Committee, RPAH Zone</ethicname>
      <ethicaddress>Research Development Office
Royal Prince Alfred Hospital
Missenden Road
Camperdown 
NSW 2050</ethicaddress>
      <ethicapprovaldate>15/06/2015</ethicapprovaldate>
      <hrec>X14-0337 and HREC/14/RPAH/453</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Paul Forrest</name>
      <address>Department of Anaesthetics
Royal Prince Alfred Hospital
Missenden Road
Camperdown 
NSW 2050</address>
      <phone>+61 2 9515 8507</phone>
      <fax />
      <email>paul.forrest@sydney.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Paul Forrest</name>
      <address>Department of Anaesthetics
Royal Prince Alfred Hospital
Missenden Road
Camperdown 
NSW 2050</address>
      <phone>+61 2 9515 8507</phone>
      <fax />
      <email>paul.forrest@sydney.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>paul forrest</name>
      <address>Department of Anaesthetics
Royal Prince Alfred Hospital
Missenden Road
Camperdown 
NSW 2050</address>
      <phone>+61 2 9515 8507</phone>
      <fax />
      <email>paul.forrest@sydney.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>paul forrest</name>
      <address>Department of Anaesthetics
Royal Prince Alfred Hospital
Camperdown 2050</address>
      <phone>+61 2 9515 8507</phone>
      <fax />
      <email>paul.forrest@sydney.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>